StockData
Canopy Growth Corp logo

Canopy Growth Corp (CGC) stock

CGCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 3/30
$0.50−0.03 (-5.63%)

Close on Nov 18, 2026Market cap $212.15MP/E –Yield –

Canopy Growth r&d expenses

Research and development expenses are spending on new products and technology.

Canopy Growth's R&D Expenses for the twelve months ending Mar 31, 2021 was C$57.58M. For fiscal 2026 it was C$2.61M, down 4.7% from the year before. The highest annual figure on record is C$61.81M in fiscal 2020.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Mar 31, 2026C$2.61M-4.7%
FY2025Mar 31, 2025C$2.74M-40.5%
FY2024Mar 31, 2024C$4.61M-78.8%
FY2023Mar 31, 2023C$21.72M-32.7%
FY2022Mar 31, 2022C$32.26M-44.0%
FY2021Mar 31, 2021C$57.58M-6.8%
FY2020Mar 31, 2020C$61.81M+305.6%
FY2019Mar 31, 2019C$15.24M+642.2%
FY2018Mar 31, 2018C$2.05M+153.5%
FY2017Mar 31, 2017C$810.00K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2021CQ1 2021Mar 31, 2021C$57.58M–

More Canopy Growth figures

See a number that looks wrong?